Pursuant to SEBI circular SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024, Adeshwar Meditex has informed that it enclosed the Investor Grievance Redressal Report under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 in the format specified therein, for the quarter ended December 31, 2024.
The above information is a part of company’s filings submitted to BSE.